Autopsy report · NCT02932475
Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
Cause of deathFutility
“Recommendation by the DSMB that the study be stopped for futility”
Life of this trial
- Registered 1 year before it started.
- Ran for about 5 years 1 month before it stopped.
- 831 participants enrolled.
- Results were posted on the registry 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes; Pregnancy
- Interventions
- Metformin; Placebo
- Participants
- 831
- Sites
- 10
- Countries
- United States
Trials that died the same way
- ATG Plus Low-dose PT-Cy for GVHD Prevention
“DSMB recommended halting the study owing to futility after the first interim analysis in August 2024.” - Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase
“The independent DSMB recommended that the study be stopped for futility following interim efficacy analysis.” - Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
“The study stopped due to futility” - Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
“DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.” - Comparison Between Radiofrequency and Balloon Compression in the Treatment of Idiopathic Trigeminal Neuralgia
“Study halted due to futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.